Tag: License Agreement

August 21, 2019

Cara Therapeutics and Enteris BioPharma Enter Commercial License Agreement

Cara Therapeutics (NASDAQ:CARA) has announced it has entered into a license agreement with Enteris BioPharma for oral formulation rights to...
December 19, 2018

Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies

Eli Lilly (NYSE:LLY) and Aduro Biotech (NASDAQ:ADRO) today announced a research collaboration and exclusive license agreement for Aduro’s cGAS-STING Pathway...
December 14, 2018

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement

Orchard Therapeutics (NASDAQ:ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare...
September 28, 2018
September 27, 2018

DiaMedica Therapeutics and Ahon Pharma Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke

Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,...
August 7, 2018

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China

Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin)...
July 13, 2018

Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories

Arcus Biosciences (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that Taiho Pharmaceutical exercised its...